Johnson & Johnson's Cilag to sell up to 11.8 million Idorsia shares
Zurich
Johnson & Johnson’s Cilag Holding will offer up to approximately 11.8 million existing ordinary shares in Idorsia Ltd in an accelerated bookbuilding to commence on Wednesday, the transaction’s bookrunner said, according to Reuters. The sale corresponds to approximately 8.3% of Swiss drugmaker Idorsia’s outstanding ordinary share capital. Goldman Sachs will act as sole bookruner on the sale.
Related Posts